To treat rare immune deficiency disease, scientists repurpose bone marrow transplant drug
Friday, September 2, 2011 - 11:30
in Health & Medicine
A new study reports that a drug already approved by the U.S. Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome. People with the syndrome are more susceptible to potentially life-threatening bacterial and viral infections, particularly human papillomavirus infections, which cause skin and genital warts and can lead to cancer.